What is it about?

Not alway the disappearance of the virus from the blood means a complete healing. It can remain hidden in the hepatic cell and can get back to life when the subject undergoes a therapy that strongly reduces his/hes immuno defences.

Featured Image

Why is it important?

Rheumatologic patients offen undergo biologic therapies, which are potent immunosuppressors.

Perspectives

The data reported in our study suggest that Caucasian patients are less exposed to the risk of virus reactivation as compared to Asiatic patients. These results would help to optimize guidelines.

Professor Michele Barone
University of Bari

Read the Original

This page is a summary of: Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection, Hepatology, February 2015, Wiley,
DOI: 10.1002/hep.27716.
You can read the full text:

Read

Contributors

The following have contributed to this page